Literature DB >> 1593688

Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer.

J A Petros1, W J Catalona.   

Abstract

Between 1983 and 1991 we saw 521 consecutive patients who elected to undergo radical prostatectomy for clinically localized prostatic carcinoma. We performed staging pelvic lymphadenectomy to avoid radical prostatectomy in patients with pelvic lymph node metastases who would be unlikely to be cured by the operation. However, we found that significantly fewer patients had lymph node metastases than historical reports would have led us to predict. Of 32 patients with clinical stage A1 disease none had positive nodes, compared to 2 of 61 (3.3%) with stage A2, 10 of 189 (5.3%) with stage B1 and 23 of 236 (9.7%) with stage B2 disease. We conclude that this lower incidence of nodal involvement relative to previous reports reflects a true change in the stage at which prostate cancer currently is diagnosed. We postulate that a higher index of suspicion, earlier detection, more aggressive intervention to establish the diagnosis, use of ultrasound guided prostate biopsies and more widespread screening for prostate cancer contribute to the lower incidence of occult lymph node metastases in patients with clinically localized prostate cancer.

Entities:  

Mesh:

Year:  1992        PMID: 1593688     DOI: 10.1016/s0022-5347(17)37630-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

Review 1.  [The role of pelvic lymphadenectomy in clinically localised prostate cancer].

Authors:  M Schumacher; F C Burkhard; U E Studer
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

2.  Accuracy and cost of intraoperative lymph node frozen sections at radical prostatectomy.

Authors:  M P Young; R S Kirby; E P O'Donoghue; M C Parkinson
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

Review 3.  Stage T1c prostate cancer: defining the appropriate staging evaluation and the role for pelvic lymphadenectomy.

Authors:  M C Beduschi; R Beduschi; J E Oesterling
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

4.  The changing pattern of prostate cancer in Nigerians: current status in the southeastern states.

Authors:  Paul D Ekwere; S N Egbe
Journal:  J Natl Med Assoc       Date:  2002-07       Impact factor: 1.798

Review 5.  Extended lymph node dissection for prostate cancer.

Authors:  Stephan Jeschke; Fiona C Burkhard; Ramesh Thurairaja; Nivedita Dhar; Urs E Studer
Journal:  Curr Urol Rep       Date:  2008-05       Impact factor: 3.092

Review 6.  [Locally advanced prostate carcinoma (T2b-T4 N0) without and with clinical evidence of local progression (Tx N+) with lymphatic metastasis. Is radiotherapy for pelvic lymphatic metastasis indicated or not?].

Authors:  T Wiegel; W Hinkelbein
Journal:  Strahlenther Onkol       Date:  1998-05       Impact factor: 3.621

Review 7.  Role of lymphadenectomy in clinically organ-confined prostate cancer.

Authors:  Nivedita Bhatta Dhar; Fiona C Burkhard; Urs E Studer
Journal:  World J Urol       Date:  2007-02-14       Impact factor: 4.226

8.  Role of pelvic lymph node dissection in prostate cancer treatment.

Authors:  Jae Young Joung; In-Chang Cho; Kang Hyun Lee
Journal:  Korean J Urol       Date:  2011-07-24

9.  [The conformal radiotherapy of localized prostatic carcinoma: acute tolerance and early efficacy].

Authors:  D Zierhut; M Flentje; G Sroka-Perez; V Rudat; R Engenhart-Cabillic; M Wannenmacher
Journal:  Strahlenther Onkol       Date:  1997-02       Impact factor: 4.033

Review 10.  Should laparoscopy be the standard approach used for pelvic lymph node dissection?

Authors:  J C Kim; G S Gerber
Journal:  Curr Urol Rep       Date:  2001-04       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.